Correlation Between AVROBIO and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both AVROBIO and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and Crispr Therapeutics AG, you can compare the effects of market volatilities on AVROBIO and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Crispr Therapeutics.
Diversification Opportunities for AVROBIO and Crispr Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AVROBIO and Crispr is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of AVROBIO i.e., AVROBIO and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between AVROBIO and Crispr Therapeutics
Given the investment horizon of 90 days AVROBIO is expected to under-perform the Crispr Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AVROBIO is 1.37 times less risky than Crispr Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Crispr Therapeutics AG is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 5,301 in Crispr Therapeutics AG on August 26, 2024 and sell it today you would lose (513.00) from holding Crispr Therapeutics AG or give up 9.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 67.27% |
| Values | Daily Returns |
AVROBIO vs. Crispr Therapeutics AG
Performance |
| Timeline |
| AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Crispr Therapeutics |
AVROBIO and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AVROBIO and Crispr Therapeutics
The main advantage of trading using opposite AVROBIO and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
| Crispr Therapeutics vs. Eliem Therapeutics | Crispr Therapeutics vs. HCW Biologics | Crispr Therapeutics vs. Scpharmaceuticals | Crispr Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |